Opioid OD Survivors Have Triple Rate Of Repeat Overdoses Than Previously Estimated

Follow Drugslib on

By Dennis Thompson HealthDay Reporter

Medically reviewed by Carmen Pope, Senior Medical Editor, B. Pharm. Last updated on May 8, 2026.

via HealthDay

FRIDAY, May 8, 2026 — People hospitalized for opioid overdose have a higher rate of subsequent OD than previously thought, a new study says.

Previously, it was estimated that about 6% of people who survived an opioid overdose wound up with a repeat overdose during the following year.

But new results indicate that 21% experience a repeat OD after an emergency department visit for opioid overdose, researchers reported May 7 in the Journal of the American Medical Association.

Patients’ risk of death also increased alongside their number of additional overdoses, the study found.

Increased use of powerful synthetic opioids like fentanyl are fueling the rising risk of repeat overdose, researchers said.

“Most older studies were conducted before the introduction of fentanyl into the unregulated drug supply,” lead researcher Robert Kleinman said in a news release. Kleinman is an assistant professor of psychiatry at the University of Toronto in Canada.

“The current fentanyl supply is highly toxic and associated with a greater risk of overdose or death,” he said.

For the new study, researchers tracked nearly 28,500 opioid overdose survivors treated in Ontario, Canada ERs between 2017 and 2023.

Within 30 days, 2% of those treated for opioid overdose had died and 6% had experienced another overdose, researchers found.

After a year, 9% had died and 21% suffered a repeat overdose, the data showed.

“These elevated risks after leaving the hospital highlight the importance of ensuring that interventions such as opioid agonist treatments and take-home naloxone are available and accessible for opioid overdose survivors,” Kleinman said.

Worse, these numbers are likely underestimates, given that researchers couldn’t track opioid overdoses that didn’t result in an ER visit. More research is needed to figure out the true risk of death and repeat overdose, researchers said.

“The elevated mortality risk observed in this study is highly concerning,” senior researcher Paul Kurdyak said in a news release. Kurdyak is a senior scientist with the Institute for Clinical Evaluative Sciences in Toronto.

“The development of evidence-based care pathways for when individuals with opioid use disorders show up to an Emergency Department with an overdose or in withdrawal may help to both reduce the high mortality rate and help people access treatment,” he added.

Sources

  • Institute for Clinical Evaluative Sciences, news release, May 7, 2026
  • Journal of the American Medical Association, May 7, 2026

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2026-05-09 02:11

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords